Thermo Fisher Scientific (TMO) Cash from Investing Activities (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Cash from Investing Activities for 18 consecutive years, with -$9.0 billion the latest figure, recorded in Q1 2026.

• Cash from Investing Activities for Q1 2026 came in at -$9.0 billion, down 1600.38% year-over-year; the trailing twelve-month figure through Mar 2026 was -$12.5 billion (down 187.71% YoY), and the FY2025 annual result was -$4.0 billion, up 30.71% from the prior year.
• Cash from Investing Activities was -$9.0 billion for Q1 2026 at Thermo Fisher Scientific, down from $891.0 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $891.0 million in Q4 2025 and troughed at -$9.0 billion in Q1 2026.
• Average Cash from Investing Activities over 5 years is -$1.5 billion, with a median of -$527.0 million recorded in 2025.
• Year-over-year, Cash from Investing Activities jumped 4355.0% in 2025 and tumbled 1600.38% in 2026.
• Over 5 years, Cash from Investing Activities stood at -$525.0 million in 2022, then rose by 28.38% to -$376.0 million in 2023, then surged by 105.32% to $20.0 million in 2024, then surged by 4355.0% to $891.0 million in 2025, then tumbled by 1105.72% to -$9.0 billion in 2026.
• Per Business Quant data, the three most recent Cash from Investing Activities figures were -$9.0 billion in Q1 2026, $891.0 million in Q4 2025, and -$4.1 billion in Q3 2025.